
    
      The clinical trial Phase 1, open-label, dose-escalation to evaluate the safety, tolerability,
      and initial assessment of immunogenicity of the vaccine Nanocovax intramuscularly in healthy
      Vietnamese adult volunteers.

      The clinical trial Phase 2, randomization, double-blind, multicenter, placebo-controlled to
      evaluate the safety, immunogenicity, and determined the optimal dose of the Vaccine Nanocovax
      intramuscularly in healthy volunteers.
    
  